CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
151 hedge funds and large institutions have $1.02B invested in Cymabay Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
+12
Holders Change %
+8.63%
% of All Funds
2.38%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.14%
New
45
Increased
42
Reduced
39
Closed
32
Calls
$3.85M
Puts
$225K
Net Calls
+$3.62M
Net Calls Change
+$531K
Top Buyers
| 1 |
BlackRock
New York
|
$82.2M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$41.6M |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
$21.9M |
| 4 |
State Street
Boston,
Massachusetts
|
$25.3M |
| 5 |
Jennison Associates
New York
|
$18.3M |
